CIK 0001514183 · Non-accelerated filer<br>Smaller reporting company
Silo Pharma, Inc.
Sign in to watch- Ticker
- SILO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462137136
- Phone
- (718) 400-9031
- Business address
- 677 N. WASHINGTON BLVD, SARASOTA, FL, 34236
- Former names
- Uppercut Brands, Inc., Point Capital, Inc., Gold Swap Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-19 | Weisblum Eric CEO and President | Purchase | +200 | $2.68 | $536 | 154,724 |
| 2022-12-14 | Weisblum Eric CEO and President | Purchase | +263 | $3.17 | $834 | 154,524 |
| 2022-12-13 | Weisblum Eric CEO and President | Purchase | +487 | $3.07 | $1K | 154,261 |
| 2022-06-17 | Weisblum Eric CEO, CFO and President | Purchase | +13,080 | $0.11 | $2K | 7,724,643 |
| 2021-12-29 | Linsley Wayne Director | Grant or award · Non-Qualified Stock Option | +171,233 | 171,233 | ||
| 2021-12-29 | Linsley Wayne Director | Grant or award · Non-Qualified Stock Option | +171,233 | 171,233 | ||
| 2021-12-29 | Linsley Wayne Director | Grant or award · Non-Qualified Stock Option | +171,233 | 342,466 | ||
| 2021-12-29 | Munoz Kevin Director | Grant or award · Non-Qualified Stock Option | +171,233 | 171,233 | ||
| 2021-12-13 | Weisblum Eric Chief Executive Officer | Purchase | +17,500 | $0.14 | $2K | 7,711,563 |
| 2021-12-10 | Weisblum Eric Chief Executive Officer | Purchase | +5,000 | $0.16 | $777 | 7,694,063 |
| 2020-04-28 | Weisblum Eric CEO, CFO and President | Grant or award | +7,630,949 | 7,689,063 | ||
| 2020-04-17 | Weisblum Eric CHIEF EXECUTIVE OFFICER | Grant or award | +7,630,949 | 7,988,663 | ||
| 2019-10-22 | Weisblum Eric CEO, CFO and President | Purchase | +200 | $0.45 | $90 | 58,114 |
| 2019-10-15 | Weisblum Eric CEO, CFO and President | Purchase | +200 | $0.38 | $76 | 57,914 |
| 2019-10-15 | Weisblum Eric CEO, CFO and President | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2019-06-17 | Weisblum Eric CEO, CFO and President | Purchase | +57,714 | $0.00 | $115 | 57,714 |
| 2019-04-15 | Weisblum Eric CEO, CFO and President | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2019-04-15 | Weisblum Eric CEO, CFO and President | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2016-02-10 | Parker Van Eps Director | Other disposition · Stock option | −112,500 | 0 | ||
| 2015-01-01 | Stone, Joel Alan Director | Other acquisition · Stock option (right to buy) | +112,500 | 0 |
Page 3 of 4 · 66 trades